Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Sells

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 1, 1996
Cyclosporin-induced cerebellar syndrome in a pancreatico-renal transplant recipientR Rustom, A P Moore, A N Bowden, et al.
Transplantation Proceedings|February 1, 1987
Three year experience of donor specific transfusion and concomitant cyclosporine AA N Hillis, J Duguid, C M Evans, et al.
Transplant Immunology|May 26, 1999
Localization of C-X-C and C-C chemokines to renal tubular epithelial cells in human kidney transplants is not confined to acute cellular rejectionJ S Sibbring, A Sharma, I W McDicken, et al.
Transplantation Proceedings|February 1, 1997
Analysis of factors affecting the outcome of renal transplantation in older peopleA K Sharma, M Brown, J Connolly, et al.
Transplantation Proceedings|September 1, 1977
A predictive test of renal viabilityR A Sells, P J Bore, G A McLaughlin, et al.
Cancer Treatment Reviews|December 1, 1987
Reduction in doxorubicin toxicity following liposomal deliveryR A Sells, I T Gilmore, R R Owen, et al.
Anti-Cancer Drugs|April 1, 1992
A phase I clinical evaluation of liposome-entrapped doxorubicin (Lip-Dox) in patients with primary and metastatic hepatic malignancyR R Owen, R A Sells, I T Gilmore, et al.
Transplantation|March 1, 1972
Active enhancement of rat renal allografts with soluble splenic antigenJ P Kim, T Shaipanich, R A Sells, et al.
Transplantation Proceedings|February 1, 1987
Symptomatic renal osteodystrophy after renal transplantation: treatment with 1-alpha-hydroxycholecalciferolP S Williams, A N Hillis, A J Carty, et al.
Transplantation Proceedings|December 29, 1998
A prospective randomised study of CSA monotherapy versus CSA plus mycophenolate mofetil in cadaveric renal transplant recipientsR A Sells, A Bakran, M W Brown, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 1, 1996
Cyclosporin-induced cerebellar syndrome in a pancreatico-renal transplant recipientR Rustom, A P Moore, A N Bowden, et al.
Transplantation Proceedings|February 1, 1987
Three year experience of donor specific transfusion and concomitant cyclosporine AA N Hillis, J Duguid, C M Evans, et al.
Transplant Immunology|May 26, 1999
Localization of C-X-C and C-C chemokines to renal tubular epithelial cells in human kidney transplants is not confined to acute cellular rejectionJ S Sibbring, A Sharma, I W McDicken, et al.
Transplantation Proceedings|February 1, 1997
Analysis of factors affecting the outcome of renal transplantation in older peopleA K Sharma, M Brown, J Connolly, et al.
Transplantation Proceedings|September 1, 1977
A predictive test of renal viabilityR A Sells, P J Bore, G A McLaughlin, et al.
Cancer Treatment Reviews|December 1, 1987
Reduction in doxorubicin toxicity following liposomal deliveryR A Sells, I T Gilmore, R R Owen, et al.
Anti-Cancer Drugs|April 1, 1992
A phase I clinical evaluation of liposome-entrapped doxorubicin (Lip-Dox) in patients with primary and metastatic hepatic malignancyR R Owen, R A Sells, I T Gilmore, et al.
Transplantation|March 1, 1972
Active enhancement of rat renal allografts with soluble splenic antigenJ P Kim, T Shaipanich, R A Sells, et al.
Transplantation Proceedings|February 1, 1987
Symptomatic renal osteodystrophy after renal transplantation: treatment with 1-alpha-hydroxycholecalciferolP S Williams, A N Hillis, A J Carty, et al.
Transplantation Proceedings|December 29, 1998
A prospective randomised study of CSA monotherapy versus CSA plus mycophenolate mofetil in cadaveric renal transplant recipientsR A Sells, A Bakran, M W Brown, et al.
Pageof 11